Govt to support some public sector companies with grants under Mission Covid Suraksha to augment vaccine production

The Government has decided to support some public sector companies with grants under the Mission COVID Suraksha with a view to augment the vaccine production.

 

One such company is the Hyderabad based Indian Immunological limited, IIL, which is a facility under the PSU, National Dairy Development Board. The Ministry of Science and Technology in a statement said, a technical collaboration agreement has been reached between IIL and Bharat Biotech, for IIL to supply the drug substance to Bharat Biotech. The substance is required  for manufacturing of Covaxin Vaccine.

 

The Managing



Director of Indian Immunological Limited, Dr K Anand Kumar said that the IIL is planning to start the production of  drug substance for Covaxin from next month. Stating that Indian Immunologicals is expected to produce the drug substance for about 10 to 15 million doses per month, Dr Kumar said, it will be initially 2 to 3 million doses and will be scaled up to 6 to 7 million per month later in the year.

 

Under Atmanirbhar Bharat 3.0, Mission COVID Suraksha was announced by the Government to accelerate the development and production of Indigenous COVID Vaccines.